CVRX - CVRx, Inc. Quarterly EPS earnings growth

CVRX (CVRx, Inc.) - company brandmark

CVRx, Inc. (CVRX) is implementing ESG standards in the development of durable cardiac implants to optimize energy consumption. Tracking quarterly EPS growth demonstrates profit dynamics, where the current metric equals -5.80. The company is scaling its sales force while eschewing mergers. The production of neurostimulators in the US relies on FDA certification and insurance coverage, ensuring stable product output.

cvrx.com (CVRX) Year-over-year earnings per share growth for the last 12 months: for the period 07/04/2022 - 11/11/2026

Summary analytical data breakdowns for CVRx Inc (CVRX)

- share price and consensus valuation forecast:
Stock Quotes CVRx|CVRX - Fair Value Consensus
- market capitalization statistics:
Market Capitalization CVRx, Inc|CVRX - Company Buyout Price
- balance sheet net asset value indicators:
Net Assets per Single Share CVRx, Inc.|CVRX - Accounting Capitalization|Market Capitalization to Book Value Ratio cvrx.com|CVRX - Cumulative Company Assets
- debt level and financial liquidity data:
Total Debt to Equity Ratio CVRx, Inc.|CVRX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital CVRx, Inc.|CVRX - Company Total Debt|Debt to Book Value CVRx, Inc|CVRX - Company Long-Term Debt|Company Short-Term Debt CVRx, Inc.|Quick Liquidity Indicator cvrx.com
- earnings and market multiples details:
CVRX - Company Profit|Projected Future Earnings CVRx, Inc.|CVRX - Company Value to Net Income|Forward P/E Multiple CVRx, Inc|CVRX - Price to Earnings Adjusted for Growth Rate|EV/EBITDA Multiple CVRx, Inc|CVRX - Operating profit EBITDA|Earnings per share for the last twelve months CVRx, Inc.|CVRX - Earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months cvrx.com|CVRX - Net earnings per one share growth for the current year|Earnings growth forecast for next year CVRx, Inc.
Basic company analysis:CVRx, CVRX
Finished products of CVRx Inc

The integration of Barostim therapy into clinical protocols through partnerships with cardiologists directly impacts the monetization of CVRx, Inc. (CVRX) innovations. Analyzing this quarterly EPS chart, an investor can see the rate of change in net income per share. This indicator serves as a navigator for fundamental recovery, capturing the real growth in business profitability. While the growth of this metric confirms the effectiveness of the expansion, buying at the peak without considering a margin of safety risks freezing capital.

Direct competitors

REGN (Regeneron) - Year-over-year net earnings per share growth for the last 12 months|iRhythm Technologies, Inc. - Year-over-year earnings per one share growth for the last 12 months|LNTH (Lantheus Medical Imaging) - Quarterly EPS earnings growth|Mineralys Corp (MLYS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months HeartFlow (HTFL)|kestramedical.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth ESPR (Esperion)|AMRN - Year-over-year net earnings per share growth for the last 12 months|AVR: Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share change for the last twelve months Tenaya Therapeutics TNYA|MIST: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Cardiol Therapeutics Inc.|Year-over-year net earnings per share growth for the last 12 months BEAT|Year-over-year earnings per share growth for the last twelve months TENX|Year-over-year earnings per share growth for the last twelve months Adagio Medical Holdings Inc. (ADGM)|BCDA (BioCardia Inc) - Year-over-year earnings per one share growth for the last 12 months|Catheter Precision - Year-over-year net earnings per share growth for the last 12 months|ABIO: Year-over-year earnings per share growth for the last 12 months|Acasti - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months AVTE (Aerovate Therapeutics Inc.)|VERV: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Windtree Therapeutics, Inc. (WINT)